| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Thoracic | 12 | 2025 | 101 | 2.300 |
Why?
|
| Blood Vessel Prosthesis Implantation | 13 | 2026 | 246 | 1.960 |
Why?
|
| Early Detection of Cancer | 8 | 2022 | 558 | 1.940 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 1110 | 1.890 |
Why?
|
| Thoracic Surgery | 7 | 2024 | 71 | 1.710 |
Why?
|
| Emigrants and Immigrants | 6 | 2018 | 49 | 1.550 |
Why?
|
| Endovascular Procedures | 12 | 2026 | 401 | 1.470 |
Why?
|
| Transcatheter Aortic Valve Replacement | 7 | 2021 | 79 | 1.400 |
Why?
|
| Cardiac Surgical Procedures | 7 | 2024 | 510 | 1.270 |
Why?
|
| Aortic Valve | 10 | 2023 | 258 | 1.200 |
Why?
|
| Aortic Aneurysm | 5 | 2020 | 72 | 1.060 |
Why?
|
| Societies, Medical | 5 | 2024 | 687 | 1.050 |
Why?
|
| Patient Navigation | 3 | 2018 | 17 | 1.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2021 | 192 | 1.020 |
Why?
|
| Colonoscopy | 3 | 2022 | 317 | 0.900 |
Why?
|
| Aortic Valve Stenosis | 3 | 2021 | 155 | 0.890 |
Why?
|
| Aorta, Thoracic | 5 | 2026 | 154 | 0.750 |
Why?
|
| Surgeons | 3 | 2023 | 327 | 0.700 |
Why?
|
| Heart Valve Prosthesis | 5 | 2021 | 97 | 0.640 |
Why?
|
| Hepatitis B, Chronic | 2 | 2018 | 36 | 0.610 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2688 | 0.590 |
Why?
|
| Computed Tomography Angiography | 4 | 2022 | 190 | 0.580 |
Why?
|
| Aortography | 2 | 2018 | 60 | 0.580 |
Why?
|
| Humans | 68 | 2026 | 98370 | 0.570 |
Why?
|
| Middle Aged | 33 | 2025 | 29532 | 0.550 |
Why?
|
| Communication Barriers | 1 | 2018 | 32 | 0.540 |
Why?
|
| Chicago | 7 | 2020 | 1519 | 0.530 |
Why?
|
| Intention | 1 | 2018 | 55 | 0.530 |
Why?
|
| Aged | 25 | 2025 | 21844 | 0.520 |
Why?
|
| Health Education | 1 | 2018 | 109 | 0.520 |
Why?
|
| Retrospective Studies | 24 | 2025 | 11043 | 0.490 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 24 | 0.480 |
Why?
|
| Software | 1 | 2021 | 697 | 0.480 |
Why?
|
| Bioprosthesis | 3 | 2021 | 42 | 0.470 |
Why?
|
| Female | 41 | 2025 | 51761 | 0.470 |
Why?
|
| Male | 42 | 2025 | 47263 | 0.470 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 2 | 0.450 |
Why?
|
| Women's Health | 1 | 2016 | 120 | 0.440 |
Why?
|
| Urban Health | 1 | 2015 | 54 | 0.440 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 40 | 0.440 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 156 | 0.430 |
Why?
|
| Acute Disease | 9 | 2025 | 860 | 0.420 |
Why?
|
| Colonic Polyps | 1 | 2015 | 143 | 0.410 |
Why?
|
| Risk Assessment | 7 | 2024 | 2599 | 0.400 |
Why?
|
| Mass Screening | 4 | 2020 | 751 | 0.380 |
Why?
|
| Treatment Outcome | 18 | 2024 | 9770 | 0.380 |
Why?
|
| Michigan | 7 | 2021 | 59 | 0.370 |
Why?
|
| Education, Medical | 1 | 2015 | 229 | 0.360 |
Why?
|
| Aorta | 4 | 2022 | 276 | 0.360 |
Why?
|
| Primary Health Care | 1 | 2016 | 402 | 0.360 |
Why?
|
| Health Status Disparities | 1 | 2015 | 244 | 0.360 |
Why?
|
| Endocarditis, Bacterial | 2 | 2020 | 38 | 0.310 |
Why?
|
| Stents | 4 | 2021 | 440 | 0.310 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2021 | 255 | 0.300 |
Why?
|
| Minority Groups | 3 | 2020 | 158 | 0.300 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 369 | 0.300 |
Why?
|
| Hospital Mortality | 7 | 2020 | 523 | 0.300 |
Why?
|
| United States | 11 | 2024 | 8262 | 0.300 |
Why?
|
| Time Factors | 10 | 2021 | 5577 | 0.300 |
Why?
|
| Adult | 15 | 2023 | 29587 | 0.270 |
Why?
|
| Mesenteric Ischemia | 2 | 2018 | 9 | 0.260 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 360 | 0.250 |
Why?
|
| Religion and Psychology | 1 | 2006 | 16 | 0.250 |
Why?
|
| Morbidity | 2 | 2024 | 163 | 0.250 |
Why?
|
| Community-Institutional Relations | 1 | 2006 | 33 | 0.250 |
Why?
|
| Aortic Diseases | 2 | 2024 | 88 | 0.240 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 542 | 0.240 |
Why?
|
| Endpoint Determination | 1 | 2026 | 65 | 0.240 |
Why?
|
| Behavior Therapy | 1 | 2006 | 100 | 0.230 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 4044 | 0.230 |
Why?
|
| Spirituality | 1 | 2006 | 112 | 0.230 |
Why?
|
| China | 3 | 2020 | 277 | 0.230 |
Why?
|
| Ischemia | 2 | 2018 | 263 | 0.230 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2006 | 44 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 1116 | 0.230 |
Why?
|
| Rural Population | 1 | 2006 | 193 | 0.220 |
Why?
|
| Chronic Disease | 4 | 2024 | 988 | 0.220 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2006 | 52 | 0.220 |
Why?
|
| Religion and Medicine | 1 | 2006 | 130 | 0.220 |
Why?
|
| Risk Factors | 10 | 2024 | 6273 | 0.220 |
Why?
|
| Weight Loss | 1 | 2006 | 245 | 0.220 |
Why?
|
| Insurance Coverage | 2 | 2015 | 153 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2023 | 1100 | 0.200 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 481 | 0.190 |
Why?
|
| Healthcare Disparities | 4 | 2016 | 547 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 602 | 0.190 |
Why?
|
| Curriculum | 3 | 2015 | 636 | 0.180 |
Why?
|
| Time-to-Treatment | 2 | 2021 | 158 | 0.180 |
Why?
|
| Text Messaging | 1 | 2022 | 36 | 0.170 |
Why?
|
| Genetic Testing | 1 | 2006 | 606 | 0.170 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2021 | 32 | 0.170 |
Why?
|
| Diverticulum | 1 | 2021 | 45 | 0.170 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2021 | 15 | 0.170 |
Why?
|
| Telecommunications | 1 | 2020 | 8 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2026 | 1126 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 103 | 0.160 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 7 | 0.160 |
Why?
|
| Risk | 2 | 2020 | 660 | 0.160 |
Why?
|
| Hepatitis B Surface Antigens | 2 | 2018 | 26 | 0.160 |
Why?
|
| Intercostal Nerves | 1 | 2020 | 4 | 0.160 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 126 | 0.160 |
Why?
|
| Reoperation | 5 | 2022 | 730 | 0.160 |
Why?
|
| Endocarditis | 1 | 2020 | 26 | 0.150 |
Why?
|
| Congresses as Topic | 1 | 2020 | 123 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 212 | 0.150 |
Why?
|
| Denervation | 1 | 2020 | 27 | 0.150 |
Why?
|
| Abscess | 1 | 2020 | 94 | 0.150 |
Why?
|
| Panax | 2 | 2011 | 171 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 139 | 0.150 |
Why?
|
| Marketing of Health Services | 1 | 2019 | 15 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 7418 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 95 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2020 | 63 | 0.150 |
Why?
|
| Obesity | 1 | 2006 | 1077 | 0.150 |
Why?
|
| Patient Admission | 1 | 2020 | 123 | 0.150 |
Why?
|
| Narcotics | 1 | 2020 | 74 | 0.150 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 118 | 0.150 |
Why?
|
| Neoplasms | 1 | 2015 | 3349 | 0.150 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 171 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 149 | 0.150 |
Why?
|
| Cryosurgery | 1 | 2020 | 77 | 0.140 |
Why?
|
| Splanchnic Circulation | 1 | 2018 | 14 | 0.140 |
Why?
|
| Hospitals, High-Volume | 1 | 2019 | 47 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 241 | 0.140 |
Why?
|
| Informed Consent | 1 | 2021 | 281 | 0.140 |
Why?
|
| Device Removal | 1 | 2020 | 170 | 0.140 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2020 | 125 | 0.140 |
Why?
|
| Consensus | 1 | 2020 | 309 | 0.140 |
Why?
|
| Aortic Rupture | 1 | 2018 | 53 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2018 | 192 | 0.140 |
Why?
|
| Occult Blood | 1 | 2018 | 29 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2021 | 502 | 0.130 |
Why?
|
| Vascular Calcification | 1 | 2018 | 52 | 0.130 |
Why?
|
| Pain Management | 1 | 2020 | 194 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2021 | 602 | 0.130 |
Why?
|
| Forecasting | 1 | 2018 | 297 | 0.130 |
Why?
|
| Community Health Services | 1 | 2018 | 81 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2018 | 100 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 665 | 0.130 |
Why?
|
| Viscera | 1 | 2016 | 19 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2020 | 357 | 0.120 |
Why?
|
| Hospitals | 1 | 2019 | 335 | 0.120 |
Why?
|
| Seroepidemiologic Studies | 1 | 2016 | 59 | 0.120 |
Why?
|
| Patient Participation | 1 | 2018 | 250 | 0.120 |
Why?
|
| Prognosis | 3 | 2020 | 4126 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 992 | 0.120 |
Why?
|
| Directive Counseling | 1 | 2016 | 34 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 448 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2792 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 102 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 525 | 0.110 |
Why?
|
| Registries | 1 | 2021 | 1128 | 0.110 |
Why?
|
| Polyps | 1 | 2015 | 26 | 0.110 |
Why?
|
| Thrombosis | 1 | 2018 | 318 | 0.110 |
Why?
|
| Vietnam | 1 | 2015 | 16 | 0.110 |
Why?
|
| Cambodia | 1 | 2015 | 6 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2015 | 66 | 0.110 |
Why?
|
| Cultural Diversity | 2 | 2013 | 64 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2018 | 418 | 0.110 |
Why?
|
| Schools, Medical | 2 | 2013 | 135 | 0.110 |
Why?
|
| Communication | 1 | 2018 | 456 | 0.100 |
Why?
|
| Logistic Models | 1 | 2018 | 1276 | 0.100 |
Why?
|
| Universities | 1 | 2015 | 166 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1785 | 0.100 |
Why?
|
| Syndrome | 2 | 2024 | 442 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1290 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 667 | 0.090 |
Why?
|
| Personnel Selection | 1 | 2013 | 66 | 0.090 |
Why?
|
| Sexual and Gender Minorities | 1 | 2016 | 262 | 0.090 |
Why?
|
| Survival Rate | 3 | 2021 | 2050 | 0.090 |
Why?
|
| Age Factors | 1 | 2016 | 1974 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2011 | 135 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2013 | 194 | 0.080 |
Why?
|
| Decision Making | 1 | 2016 | 689 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2011 | 529 | 0.080 |
Why?
|
| Ginsenosides | 1 | 2011 | 124 | 0.080 |
Why?
|
| School Admission Criteria | 1 | 2010 | 30 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2011 | 252 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2024 | 381 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 464 | 0.070 |
Why?
|
| Sex Factors | 1 | 2012 | 1142 | 0.070 |
Why?
|
| Physicians | 1 | 2016 | 685 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2011 | 517 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2020 | 402 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 588 | 0.060 |
Why?
|
| Regional Blood Flow | 2 | 2018 | 194 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2006 | 28 | 0.060 |
Why?
|
| North Carolina | 1 | 2006 | 59 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 4818 | 0.060 |
Why?
|
| Focus Groups | 1 | 2006 | 214 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 189 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2006 | 178 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 663 | 0.060 |
Why?
|
| Family Health | 1 | 2006 | 157 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2021 | 415 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2008 | 337 | 0.050 |
Why?
|
| Leadership | 1 | 2006 | 160 | 0.050 |
Why?
|
| Students, Medical | 1 | 2010 | 449 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 914 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 7568 | 0.050 |
Why?
|
| Adolescent | 1 | 2016 | 10140 | 0.050 |
Why?
|
| Exercise | 1 | 2006 | 382 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2006 | 867 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 3228 | 0.050 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2021 | 8 | 0.040 |
Why?
|
| Cathartics | 1 | 2022 | 28 | 0.040 |
Why?
|
| Subclavian Artery | 1 | 2021 | 43 | 0.040 |
Why?
|
| Heart Valves | 1 | 2021 | 22 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2021 | 55 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2021 | 161 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 92 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2024 | 356 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2020 | 32 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 234 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 278 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 302 | 0.040 |
Why?
|
| Triage | 1 | 2021 | 151 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 420 | 0.040 |
Why?
|
| Patient Preference | 1 | 2021 | 136 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 309 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2020 | 76 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 225 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2018 | 21 | 0.040 |
Why?
|
| Episode of Care | 1 | 2018 | 9 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 3032 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 252 | 0.030 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 17 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 49 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2019 | 170 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 907 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 301 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2022 | 528 | 0.030 |
Why?
|
| Kidney | 1 | 2022 | 1121 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 2009 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2018 | 345 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2016 | 36 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2579 | 0.030 |
Why?
|
| Health Communication | 1 | 2016 | 15 | 0.030 |
Why?
|
| Genome, Human | 1 | 2021 | 834 | 0.030 |
Why?
|
| Stereotyping | 1 | 2016 | 21 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 305 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 41 | 0.030 |
Why?
|
| Culture | 1 | 2016 | 57 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1529 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 722 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 876 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2015 | 187 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1787 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1859 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2023 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 360 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 387 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 580 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 533 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 189 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 307 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4428 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 1502 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 676 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 375 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2678 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 565 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 546 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 2056 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 1018 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3612 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 845 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2896 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2577 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 12735 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 28981 | 0.010 |
Why?
|